2 stock market bargains to buy today

This Fool’s eyeing up these stock market bargains for their income and growth potential, as well as their low valuations.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m always on the lookout for stock market bargains to add to my portfolio. And two companies have recently attracted my attention, one of which I’ve already bought, and one I’m planning to buy. 

Stock market bargains on offer

The first stock is the insurance group Direct Line (LSE: DLG). This enterprise reported a strong trading performance in 2020, as a lower level of accidents helped offset falling sales. As a result, the company’s overall profitability increased as its loss ratio dropped. 

But despite Direct Line’s impressive performance last year, the market seems to be avoiding the business. I’m not sure why. The company expects to own a healthy profit margin again this year. What’s more, it’s returning much of its income to shareholders with dividends and share buybacks. 

To give an example of the company’s cash return potential, City analysts reckon the business will distribute 24.3p per share this year in dividends. That equates to a dividend yield of 8.4%

Of course, this is just a projection at this stage. However, I think it clearly shows the company’s income potential. 

Those of the reasons why I believe this is one of the best stock market bargains available to buy today. I already own Direct Line in my portfolio and will buy more if the shares continue to decline in value. 

Having said all of the above, the UK car insurance industry is incredibly competitive. More often than not, insurers fail to own a return on investment. Direct Line has avoided this fate, so far, but there’s no guarantee it will forever. 

Changing of the guard

I think GlaxoSmithKline (LSE: GSK) also qualifies as a stock market bargain today. It’s clear to me why investors have been avoiding the business. It’s been a terrible investment. Over the past 21 years, excluding dividends, the stock has returned -26%. 

Still, I think there’s a chance this could be about to change. Management has recently laid out new growth targets. And to help the company accomplish its aims, the group is planning to spin off its consumer healthcare division. This should produce a more focused pharmaceutical business. 

I’m sure there’s no guarantee growth will return after these changes, but I’m encouraged by management’s recent actions. The involvement of activist hedge fund Elliott Management has also helped drive change. 

As well as these initiatives, the stock looks cheap. It’s trading at a forward price-to-earnings (P/E) multiple of 13.8. Glaxo’s large US peers command multiples of 20 or more. 

Therefore, I reckon the combination of the company’s low valuation and its growth objectives suggests now’s the time to buy. That’s why I’d add GSK to my portfolio of stock market bargains, even though there’s a high chance the group may continue to struggle in the years ahead. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of Direct Line Insurance. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 75% in 5 years, I reckon this FTSE 250 still has lots to give!

Our writer explains why this FTSE 250 stock could still continue to provide growth and returns despite already being on…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 high-quality FTSE 250 stocks to consider buying

The FTSE 250 is home to some of the best investment opportunities out there. This Fool highlights two stocks for…

Read more »

Investing Articles

The Marks and Spencer share price dips! Is this my chance to buy?

Marks and Spencer was one of the hottest stocks on the market last year. With its share price falling in…

Read more »

Growth Shares

How low could the boohoo share price go?

Jon Smith explains why the enterprise value and the low risk of bankruptcy should help to prevent the boohoo share…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

Down 23% in a year! Can the Diageo share price regain £30 in 2024?

This Fool UK writer is checking the charts to see if the Diageo share price can recover from the recent…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

I wouldn’t touch this FTSE 100 stalwart with a bargepole

Despite looking like a bargain on paper, this Fool is avoiding FTSE 100 constituent Vodafone at all costs. Here he…

Read more »

Investing Articles

I’m waiting for the Rolls-Royce share price to pull back before I buy

The Rolls-Royce share price has been the Footsie's best performer in the last year. But this Fool has no intention…

Read more »

Front view photo of a woman using digital tablet in London
Dividend Shares

2 dividend stocks to take me from £0 to £9.5k in second income

Jon Smith talks through some ideas with second income potential, including one stock that has a dividend yield above 10%…

Read more »